MAM
Morse Asset Management Portfolio holdings
AUM
$456M
This Quarter Return
+7.9%
1 Year Return
+29.91%
3 Year Return
+155.16%
5 Year Return
+306.41%
10 Year Return
–
AUM
$379M
AUM Growth
+$379M
(+4%)
Cap. Flow
-$1.05M
Cap. Flow
% of AUM
-0.28%
Top 10 Holdings %
Top 10 Hldgs %
35.39%
Holding
147
New
9
Increased
60
Reduced
35
Closed
12
Top Buys
| 1 |
Roku
ROKU
|
$4.02M |
| 2 |
MongoDB
MDB
|
$2.24M |
| 3 |
Thermo Fisher Scientific
TMO
|
$1.91M |
| 4 |
Verizon
VZ
|
$1.9M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$1.88M |
Top Sells
| 1 |
KMG
KMG Chemicals Inc
KMG
|
$4.08M |
| 2 |
Alibaba
BABA
|
$3.56M |
| 3 |
Pultegroup
PHM
|
$3.46M |
| 4 |
Micron Technology
MU
|
$2.86M |
| 5 |
AbbVie
ABBV
|
$1.87M |
Sector Composition
| 1 | Consumer Discretionary | 20.42% |
| 2 | Technology | 19.06% |
| 3 | Industrials | 15.72% |
| 4 | Healthcare | 14.79% |
| 5 | Communication Services | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Roku
ROKU
$14.2B
| $4.02M | 1.06% |
+54,980
| New | +$4.02M |
|
27
3M
MMM
$82.8B
| $3.84M | 1.01% |
18,220
| – | – |
|
28
Gilead Sciences
GILD
$140B
| $3.82M | 1.01% |
49,485
+4,950
| +11% | +$382K |
|
29
Regeneron Pharmaceuticals
REGN
$61.5B
| $3.71M | 0.98% |
9,182
+3,127
| +52% | +$1.26M |
|
30
Marathon Petroleum
MPC
$54.6B
| $3.62M | 0.95% |
45,275
+775
| +2% | +$62K |
|
31
HealthEquity
HQY
$7.72B
| $3.47M | 0.91% |
36,770
+1,000
| +3% | +$94.4K |
|
|
CELG
32
DELISTED
Celgene Corp
CELG
| $3.45M | 0.91% |
38,540
+100
| +0.3% | +$8.95K |
|
33
American Express
AXP
$231B
| $3.39M | 0.89% |
31,870
+15,870
| +99% | +$1.69M |
|
34
Las Vegas Sands
LVS
$39.6B
| $3.37M | 0.89% |
56,830
-12,230
| -18% | -$726K |
|
35
Jazz Pharmaceuticals
JAZZ
$7.75B
| $3.3M | 0.87% |
19,620
-225
| -1% | -$37.8K |
|
36
Caterpillar
CAT
$196B
| $3.19M | 0.84% |
20,940
+730
| +4% | +$111K |
|
37
Analog Devices
ADI
$124B
| $3.17M | 0.84% |
34,320
-4,700
| -12% | -$435K |
|
|
38
Thermo Fisher Scientific
TMO
$186B
| $3.07M | 0.81% |
12,574
+7,830
| +165% | +$1.91M |
|
|
39
Vertex Pharmaceuticals
VRTX
$100B
| $3.05M | 0.8% |
15,815
+9,764
| +161% | +$1.88M |
|
40
Evercore
EVR
$12.4B
| $3.02M | 0.8% |
30,030
| – | – |
|
41
Palo Alto Networks
PANW
$127B
| $2.91M | 0.77% |
12,903
+1,695
| +15% | +$382K |
|
|
42
AbbVie
ABBV
$372B
| $2.85M | 0.75% |
30,165
-19,795
| -40% | -$1.87M |
|
43
Ligand Pharmaceuticals
LGND
$3.15B
| $2.74M | 0.72% |
9,980
+100
| +1% | +$27.4K |
|
|
LLL
44
DELISTED
L3 Technologies, Inc.
LLL
| $2.72M | 0.72% |
12,790
| – | – |
|
45
Apollo Global Management
APO
$77.9B
| $2.71M | 0.71% |
78,280
+45,655
| +140% | +$1.58M |
|
|
46
Verizon
VZ
$186B
| $2.63M | 0.69% |
49,330
+35,530
| +257% | +$1.9M |
|
47
Expeditors International
EXPD
$16.4B
| $2.61M | 0.69% |
35,550
| – | – |
|
48
Exxon Mobil
XOM
$487B
| $2.38M | 0.63% |
27,994
-200
| -0.7% | -$17K |
|
|
ATVI
49
DELISTED
Activision Blizzard Inc.
ATVI
| $2.33M | 0.62% |
28,055
-145
| -0.5% | -$12.1K |
|
|
FSTX
50
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $2.29M | 0.6% |
190,050
+12,550
| +7% | +$151K |
|